Authors


Allan Krumholz, MD

Latest:

Driving and Epilepsy: Issues to Discuss With Your Patients

Because automobiles are such an important aspect of our culture, driving restriction is an enormous problem for many of the 65 million individuals with epilepsy worldwide and their families.


Caleb Rans, PharmD

Latest:

Opioid Analgesics in Migraine: What Are the Alternatives?

Because opioids have been shown to increase disability and reduce quality of life in patients with migraine, the search is on for effective alternative treatments.


Giorgio Buzzi, MD

Latest:

Exploring Recurrent Isolated Sleep Paralysis

Strategies and take-home points on sleep paralysis and its counterpart, isolated sleep paralysis, a REM sleep-related parasomnia commonly associated with intense fear and anxiety.


Alcy Torres, MD, FAAP

Latest:

Pediatric Concussion: Current Trends and New Frontiers

Experts provide new insights about the challenges of concussion care for pediatric patients, including management, diagnosis, and return to a normal lifestyle.


Zakir Shaikh, MBBS

Latest:

Pediatric Concussion: Current Trends and New Frontiers

Experts provide new insights about the challenges of concussion care for pediatric patients, including management, diagnosis, and return to a normal lifestyle.


Nina Riggins, MD, PhD, FAAN, FAHS

Latest:

Letter From the Editor – Fall 2024

Nina Riggins, MD, PhD, FAAN, FAHS, UCNS Diplomate, highlighted the essential role of advocacy in advancing neurological care, particularly in improving the transition process for pediatric patients with migraine to adult care.


Alison Alford, MD

Latest:

Special Populations in Neurology: Pediatric Migraine

Neurology Times' podcast with a pediatric headache specialist and neurologist who has performed over 1000 procedures to treat migraine in children and adolescents.


Lisa A. Brenner, PhD

Latest:

TBI and Suicide: From Science to Prevention Strategies

Conceptualizing risk among patients with traumatic brain injury requires clinicians to consider multiple factors including neuroanatomic and cognitive dysfunction, and psychosocial impairment.


Riley P. Grassmeyer, MS

Latest:

TBI and Suicide: From Science to Prevention Strategies

Conceptualizing risk among patients with traumatic brain injury requires clinicians to consider multiple factors including neuroanatomic and cognitive dysfunction, and psychosocial impairment.


James P. Kelly, MD

Latest:

TBI and Suicide: From Science to Prevention Strategies

Conceptualizing risk among patients with traumatic brain injury requires clinicians to consider multiple factors including neuroanatomic and cognitive dysfunction, and psychosocial impairment.


Bharat R. Narapareddy, MD

Latest:

The Growing Epidemic of TBI in Older Patients

Despite advances in neurology, a silent epidemic of older adults who sustain a TBI is growing. The authors provide tools and tips for a geriatric approach to treatment.


Lisa N. Richey

Latest:

The Growing Epidemic of TBI in Older Patients

Despite advances in neurology, a silent epidemic of older adults who sustain a TBI is growing. The authors provide tools and tips for a geriatric approach to treatment.


Matthew E. Peters, MD

Latest:

The Growing Epidemic of TBI in Older Patients

Despite advances in neurology, a silent epidemic of older adults who sustain a TBI is growing. The authors provide tools and tips for a geriatric approach to treatment.


Brandon Lucke-Wold, MD, PhD, MCTS

Latest:

Complementary and Alternative Therapies for TBI: Key Points for Clinicians

The CAM options described here may help prevent trauma-related neurodegeneration over the long term.


Wael Ibrahim, MD

Latest:

Effective Treatment of Essential Palatal Tremor and Coexistent Bipolar Disorder: A Case Report

Clicking sounds in the patient’s ears were initially thought to be auditory hallucinations, but a thorough neurological examination revealed the true cause.


Lauren C. Frey, MD

Latest:

Epilepsy Surgery, Part 1: Refractory Seizures and Presurgical Evaluation

At least 30% of patients with epilepsy have seizures that are incompletely controlled by medical therapy; thus, nonpharmacological options are important for comprehensive care.


Angela Seabright, DO

Latest:

AAN Guidelines on Use of fMRI for Presurgical Mapping in Epilepsy

Patients with drug-resistant seizures should have an epilepsy center evaluation to confirm the diagnosis and determine the epilepsy syndrome and possible candidacy for neurosurgery. Guidelines here.


Katherine Foxhall, PhD

Latest:

A History of Migraine: Gender Ratio

Around three times more women than men have migraine. This marked difference in prevalence is one of the most well-known features of the illness. Here's what history tells us.


Jori E. Fleisher, MD, MSCE

Latest:

Benefits of Martial Arts on Movement Disorders

This podcast discusses preliminary evidence about the effects of karate on quality of life and several measures of gait, balance, and mobility in patients with PD.


Joseph Kaizer

Latest:

Music Therapy Unites the Arts and Medicine to Help Patients

Two medical students who are conservatory-trained musicians describe a memorable performance at a center for older adults with dementia.


Esther Kim

Latest:

Music Therapy Unites the Arts and Medicine to Help Patients

Two medical students who are conservatory-trained musicians describe a memorable performance at a center for older adults with dementia.


Cesar Ochoa-Lubinoff, MD, MPH, FAAP

Latest:

Phase 2 Trial for Angelman Syndrome Underway

In this podcast, Heidi Moawad, MD interviews Cesar Ochoa-Lubinoff, MD, MPH, FAAP, about recent encouraging clinical trial results in patients with Angelman syndrome.


Amir Bishay, MD

Latest:

Genetic Testing for Huntington Disease

The profound consequences of the results guide decisions about testing. Who should be tested? And, just as important, who should not?


William S. Baek, MD, FAAN

Latest:

Connecting With Neurology Patients Through Music

An interview with a neurologist who found that merely writing medical articles cannot express the impact an illness can have on patients, both literally and emotionally.


Alex Kolevzon, MD

Latest:

Developing Targeted Therapeutics in Angelman Syndrome

The genomic revolution has led to increasing opportunities to address complex neurodevelopmental conditions, taking a genetics-first approach.


Deepa Burman, MD

Latest:

New Treatment for Rare Autoimmune Disease

A new treatment for NMOSD has been found to reduce relapse, decrease re-hospitalizations, and hinder the need to treat acute attacks with corticosteroids and plasma exchange.


Lary C. Walker, PhD

Latest:

Prion-like Molecular Mechanisms in Alzheimer Disease

Although Alzheimer disease is not infectious by any common definition of the term, research over the past 20 years has confirmed long-standing speculation that the molecular mechanism driving neurodegeneration is fundamentally the same in Alzheimer disease and the prototypical infectious proteopathy-prion disease.


Jessica Ailani, MD

Latest:

A Time to Recognize and Enhance Understanding of Migraine Disorders: Jessica Ailani, MD

The director of the MedStar Georgetown Headache Center talked about recognizing the struggles of patients with migraine disorders and the importance of bringing awareness of available treatments to this patient population. [WATCH TIME: 5 minutes]


Alicia Bigica

Latest:

FibroGen's Duchenne Muscular Dystrophy Antibody Pamrevlumab Falls Short in Phase 3

The study did not meet its primary end point of change from baseline in Performance of the Upper Limb 2.0 score at 1 year.


Jenna Payesko

Latest:

FDA Rejects Duchenne Muscular Dystrophy Drug Golodirsen, Citing Safety Concerns

The regulatory agency cited 2 concerns in the complete response letter: the risk of infections related to intravenous infusion ports and renal toxicity.

© 2024 MJH Life Sciences

All rights reserved.